Cardiol Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:CRDL Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
17 Oct 25	BuyUS$100,000	David Elsley	Individual		100,000	US$1.00
17 Oct 25	BuyUS$50,000	Guillermo Torre-Amione	Individual		50,000	US$1.00

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CRDL?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	3,414,864	3.05%
Institutions	12,739,322	11.4%
Hedge Funds	15,352,317	13.7%
General Public	80,365,581	71.8%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 35.4%.

Top Shareholders

Top 25 shareholders own 27.51% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
13.7%	MM Asset Management Inc	15,352,317	US$17.1m	7,250%	1.16%
4.59%	Tejara Capital Limited	5,130,122	US$5.7m	0%	1.82%
2.44%	Ikarian Capital, LLC	2,725,000	US$3.0m	0%	0.56%
1.2%	David Elsley	1,344,500	US$1.5m	0%	no data
0.73%	Citadel Advisors LLC	819,904	US$914.9k	0%	no data
0.71%	Boothbay Fund Management, LLC	794,881	US$887.0k	0%	0.02%
0.6%	Andrew Hamer	669,947	US$747.6k	0%	no data
0.48%	Two Sigma Investments, LP	534,211	US$596.1k	31.3%	no data
0.45%	Peter Pekos	506,040	US$564.7k	0%	no data
0.42%	Integrity Alliance, LLC.	465,025	US$518.9k	6.9%	0.02%
0.3%	The Goldman Sachs Group, Inc.	332,400	US$370.9k	1.19%	no data
0.28%	Guillermo Torre-Amione	309,309	US$345.1k	0%	no data
0.22%	Morgan Stanley	250,421	US$279.4k	-27.3%	no data
0.21%	Renaissance Technologies LLC	229,806	US$256.4k	0%	no data
0.13%	Colin Stott	142,500	US$159.0k	0%	no data
0.13%	Sheets Smith Investment Management, LLC	142,097	US$158.6k	0%	0.09%
0.12%	Christopher Waddick	135,900	US$151.6k	0%	no data
0.12%	Jennifer Chao	133,334	US$148.8k	0%	no data
0.12%	Teri Loxam	133,334	US$148.8k	0%	no data
0.11%	Jane Street Group, LLC	126,957	US$141.7k	219%	no data
0.093%	Summit Equities, Inc.	104,059	US$116.1k	0%	no data
0.089%	Knoll Capital Management	100,000	US$111.6k	0%	0.07%
0.089%	1832 Asset Management L.P.	100,000	US$111.6k	0%	no data
0.089%	MGO One Seven LLC	100,000	US$111.6k	0%	no data
0.087%	PVG Asset Management Corp	97,165	US$108.4k	0%	0.22%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/06/04 21:44
End of Day Share Price	2026/06/04 00:00
Earnings	2026/03/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Cardiol Therapeutics Inc. is covered by 8 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Tyler Bussian	Brookline Capital Markets
Fozia Ahmed	Brookline Capital Markets
Edward Nash	Canaccord Genuity